Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longitudinal Evaluation of [18F]MK-6240 in AD and MCI
NCT03919669Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2019
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by University of Wisconsin–Madison. Primary endpoint: Change in [18F]MK-6240 Standard Uptake Value Ratio (SUVR) Uptake at 12 months. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03919669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919669.